These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 38148326)

  • 1. Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma.
    Song Y; Lau HC; Zhang X; Yu J
    Cancer Biol Med; 2023 Dec; 21(2):144-62. PubMed ID: 38148326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiome-bile acid axis in hepatocarcinogenesis.
    Wu L; Feng J; Li J; Yu Q; Ji J; Wu J; Dai W; Guo C
    Biomed Pharmacother; 2021 Jan; 133():111036. PubMed ID: 33378947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC.
    Sydor S; Best J; Messerschmidt I; Manka P; Vilchez-Vargas R; Brodesser S; Lucas C; Wegehaupt A; Wenning C; Aßmuth S; Hohenester S; Link A; Faber KN; Moshage H; Cubero FJ; Friedman SL; Gerken G; Trauner M; Canbay A; Bechmann LP
    Clin Transl Gastroenterol; 2020 Mar; 11(3):e00131. PubMed ID: 32352707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis.
    Pan Y; Zhang H; Li M; He T; Guo S; Zhu L; Tan J; Wang B
    Gut Microbes; 2024; 16(1):2356284. PubMed ID: 38769683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease.
    Li L; Liu T; Gu Y; Wang X; Xie R; Sun Y; Wang B; Cao H
    Front Immunol; 2022; 13():974305. PubMed ID: 36211363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions.
    Rajapakse J; Khatiwada S; Akon AC; Yu KL; Shen S; Zekry A
    Gut Microbes; 2023 Dec; 15(2):2240031. PubMed ID: 37615334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.
    Mulak A
    J Alzheimers Dis; 2021; 84(2):461-477. PubMed ID: 34569953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice.
    Zheng X; Huang F; Zhao A; Lei S; Zhang Y; Xie G; Chen T; Qu C; Rajani C; Dong B; Li D; Jia W
    BMC Biol; 2017 Dec; 15(1):120. PubMed ID: 29241453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma.
    Shen R; Ke L; Li Q; Dang X; Shen S; Shen J; Li S; Liang L; Peng B; Kuang M; Ma Y; Yang Z; Hua Y
    Hepatol Int; 2022 Apr; 16(2):396-411. PubMed ID: 35211843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota Dysbiosis Is Associated with Altered Bile Acid Metabolism in Infantile Cholestasis.
    Wang Y; Gao X; Zhang X; Xiao Y; Huang J; Yu D; Li X; Hu H; Ge T; Li D; Zhang T
    mSystems; 2019 Dec; 4(6):. PubMed ID: 31848302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota remodeling reverses aging-associated inflammation and dysregulation of systemic bile acid homeostasis in mice sex-specifically.
    Ma J; Hong Y; Zheng N; Xie G; Lyu Y; Gu Y; Xi C; Chen L; Wu G; Li Y; Tao X; Zhong J; Huang Z; Wu W; Yuan L; Lin M; Lu X; Zhang W; Jia W; Sheng L; Li H
    Gut Microbes; 2020 Sep; 11(5):1450-1474. PubMed ID: 32515683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiota - A vehicle for the prevention and treatment of hepatocellular carcinoma.
    Beyoğlu D; Idle JR
    Biochem Pharmacol; 2022 Oct; 204():115225. PubMed ID: 35998677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile Acids and Liver Cancer: Molecular Mechanism and Therapeutic Prospects.
    Zhang X; Shi L; Lu X; Zheng W; Shi J; Yu S; Feng H; Yu Z
    Pharmaceuticals (Basel); 2024 Aug; 17(9):. PubMed ID: 39338306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis.
    Chen W; Wei Y; Xiong A; Li Y; Guan H; Wang Q; Miao Q; Bian Z; Xiao X; Lian M; Zhang J; Li B; Cao Q; Fan Z; Zhang W; Qiu D; Fang J; Gershwin ME; Yang L; Tang R; Ma X
    Clin Rev Allergy Immunol; 2020 Feb; 58(1):25-38. PubMed ID: 30900136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A High-Fat, High-Cholesterol Diet Promotes Intestinal Inflammation by Exacerbating Gut Microbiome Dysbiosis and Bile Acid Disorders in Cholecystectomy.
    Xu F; Yu Z; Liu Y; Du T; Yu L; Tian F; Chen W; Zhai Q
    Nutrients; 2023 Sep; 15(17):. PubMed ID: 37686860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma: Novel understandings and therapeutic strategies based on bile acids (Review).
    Luo W; Guo S; Zhou Y; Zhu J; Zhao J; Wang M; Sang L; Wang B; Chang B
    Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 35929515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma.
    Stepien M; Lopez-Nogueroles M; Lahoz A; Kühn T; Perlemuter G; Voican C; Ciocan D; Boutron-Ruault MC; Jansen E; Viallon V; Leitzmann M; Tjønneland A; Severi G; Mancini FR; Dong C; Kaaks R; Fortner RT; Bergmann MM; Boeing H; Trichopoulou A; Karakatsani A; Peppa E; Palli D; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita HB; Skeie G; Merino S; Ros RZ; Sánchez MJ; Amiano P; Huerta JM; Barricarte A; Sjöberg K; Ohlsson B; Nyström H; Werner M; Perez-Cornago A; Schmidt JA; Freisling H; Scalbert A; Weiderpass E; Christakoudi S; Gunter MJ; Jenab M
    Int J Cancer; 2022 Apr; 150(8):1255-1268. PubMed ID: 34843121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydromyricetin improves DSS-induced colitis in mice via modulation of fecal-bacteria-related bile acid metabolism.
    Dong S; Zhu M; Wang K; Zhao X; Hu L; Jing W; Lu H; Wang S
    Pharmacol Res; 2021 Sep; 171():105767. PubMed ID: 34273490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting and refeeding triggers specific changes in bile acid profiles and gut microbiota.
    Zhang Y; Qi H; Wang L; Hu C; Gao A; Wu Q; Wang Q; Lin H; Chen B; Wang X; Wang S; Lin H; Wang W; Bi Y; Wang J; Lu J; Liu R
    J Diabetes; 2023 Feb; 15(2):165-180. PubMed ID: 36682739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis.
    Yang ZH; Liu F; Zhu XR; Suo FY; Jia ZJ; Yao SK
    World J Gastroenterol; 2021 Jun; 27(24):3609-3629. PubMed ID: 34239273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.